Clinical Trials Browser

OTHER × Waldenstrom Macroglobulinemia × ofatumumab × Clear all

NCT01536067 2016-06-10

Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia

Phase 2 Terminated

3 enrolled 4 charts

Waldenstrom Macroglobulinemia

NCT01119794 2015-08-26

Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab

Phase 2 Terminated

10 enrolled 7 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell